Zeitoun JD - Search Results

1

Inconsistencies among European Union pharmaceutical regulator safety communications: a cross-country comparison.

Zeitoun JD, Lefèvre JH, Downing N, Bergeron H, Ross JS. Zeitoun JD, et al. PLoS One. 2014 Oct 21;9(10):e109100. doi: 10.1371/journal.pone.0109100. eCollection 2014. PLoS One. 2014. PMID: 25333986 Free PMC article.

2

Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study.

Zeitoun JD, Lefèvre JH, Downing NS, Bergeron H, Ross JS. Zeitoun JD, et al. Br J Clin Pharmacol. 2015 Oct;80(4):716-26. doi: 10.1111/bcp.12643. Epub 2015 May 28. Br J Clin Pharmacol. 2015. PMID: 25808713 Free PMC article.

3

Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study.

Zeitoun JD, Lefèvre JH, Downing NS, Bergeron H, Ross JS. Zeitoun JD, et al. Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):687-94. doi: 10.1002/pds.3910. Epub 2015 Nov 11. Pharmacoepidemiol Drug Saf. 2016. PMID: 26554874

4

Post-marketing research and its outcome for novel anticancer agents approved by both the FDA and EMA between 2005 and 2010: A cross-sectional study.

Zeitoun JD, Baron G, Vivot A, Atal I, Downing NS, Ross JS, Ravaud P. Zeitoun JD, et al. Int J Cancer. 2018 Jan 15;142(2):414-423. doi: 10.1002/ijc.31061. Epub 2017 Oct 12. Int J Cancer. 2018. PMID: 28929484

5

Readmissions After Surgery: A French Nationwide Cross-Sectional Study of 1,686,602 Procedures Performed in 2010.

Lefèvre JH, Reboul-Marty J, de Vaugrigneuse S, Zeitoun JD. Lefèvre JH, et al. Among authors: zeitoun jd. World J Surg. 2017 Jan;41(1):31-38. doi: 10.1007/s00268-016-3740-6. World J Surg. 2017. PMID: 27718005

6

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010.

Downing NS, Shah ND, Aminawung JA, Pease AM, Zeitoun JD, Krumholz HM, Ross JS. Downing NS, et al. Among authors: zeitoun jd. JAMA. 2017 May 9;317(18):1854-1863. doi: 10.1001/jama.2017.5150. JAMA. 2017. PMID: 28492899 Free PMC article.

7

Impact of resident and fellow changeovers on patient outcomes: a nationwide cross-sectional study.

Zeitoun JD, Reboul-Marty J, Lefèvre JH. Zeitoun JD, et al. Eur J Public Health. 2017 Dec 1;27(6):960-965. doi: 10.1093/eurpub/ckx072. Eur J Public Health. 2017. PMID: 28549099

8

Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study.

Zeitoun JD, Ross JS, Atal I, Vivot A, Downing NS, Baron G, Ravaud P. Zeitoun JD, et al. BMJ Open. 2017 Dec 21;7(12):e018587. doi: 10.1136/bmjopen-2017-018587. BMJ Open. 2017. PMID: 29273664 Free PMC article.

9

Factors Associated With Postmarketing Research for Approved Indications for Novel Medicines Approved by Both the FDA and EMA Between 2005 and 2010: A Multivariable Analysis.

Zeitoun JD, Ross JS, Atal I, Vivot A, Downing NS, Baron G, Ravaud P. Zeitoun JD, et al. Clin Pharmacol Ther. 2018 Nov;104(5):1000-1007. doi: 10.1002/cpt.1038. Epub 2018 Feb 24. Clin Pharmacol Ther. 2018. PMID: 29377075

10

Functional digestive symptoms and quality of life in patients with Ehlers-Danlos syndromes: results of a national cohort study on 134 patients.

Zeitoun JD, Lefèvre JH, de Parades V, Séjourné C, Sobhani I, Coffin B, Hamonet C. Zeitoun JD, et al. PLoS One. 2013 Nov 22;8(11):e80321. doi: 10.1371/journal.pone.0080321. eCollection 2013. PLoS One. 2013. PMID: 24278273 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters